The Application Of Integrated Psychoeducation And Psychopharmacological Strategies In The Management Of Generalized Anxiety Disorder In Patients With Comorbid Type 2 Diabetes Mellitus: A Comprehensive Case Report

Abstract

Type 2 Diabetes Mellitus (T2DM) is a global health challenge frequently accompanied by significant psychological comorbidities. Generalized Anxiety Disorder (GAD) has a high prevalence among diabetic patients, with both conditions influencing each other through complex neuroendocrine mechanisms. Emotional instability and excessive worry often serve as primary barriers to achieving optimal glycemic control. This case report aims to evaluate the effectiveness of a holistic approach combining advanced psychopharmacology and structured psychoeducation in a young adult patient with a genetic risk of T2DM. Mr. MT, a 32-year-old male, presented with dominant physical complaints including palpitations, dizziness, and persistent epigastric pain for six months. Through in-depth psychiatric evaluation, a pattern of uncontrollable worry (overthinking) was identified, related to family burdens and fear of hereditary disease after discovering an increase in HbA1c levels. Laboratory results showed drastic fluctuations in glycemic control, with peak HbA1c reaching 12.9%. The patient was diagnosed with Generalized Anxiety Disorder with somatic manifestations exacerbated by metabolic conditions. Management involved the use of Escitalopram, low-dose Aripiprazole, Alprazolam, and Trihexyphenidyl, integrated with family psychoeducation interventions and relaxation techniques. Case analysis indicates that chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis due to anxiety triggers cortisol release, inducing insulin resistance and hyperglycemia. The use of Aripiprazole as an SSRI augmentation agent provided dopaminergic stability, helping to reduce cognitive distress. Psychoeducation was proven to increase the patient's self-efficacy in diabetes management and improve medication adherence, which directly correlated with decreased HbA1c levels. The integration of mental health services into diabetes management is crucial. A multidimensional approach encompassing pharmacological stabilization and psychosocial reinforcement through psychoeducation is key to breaking the bidirectional cycle between anxiety and diabetes.